cleavag
mechan
sever
acut
respiratori
syndrom
sar
coronaviru
main
proteinas
pro
pro
octapeptid
avlqsgfr
studi
use
molecular
mechan
mm
quantum
mechan
qm
catalyt
dyad
activ
pocket
domain
ii
seem
polar
electron
densiti
peptid
bond
gln
ser
octapeptid
lead
increas
posit
charg
c
co
gln
neg
charg
n
nh
ser
possibl
enhanc
chemic
bond
gln
ser
base
distort
key
theori
anal
biochem
examin
scissil
peptid
bond
gln
ser
found
solidifi
hybrid
peptid
bond
chang
carbonyl
group
co
gln
ch
cf
lead
break
bond
system
peptid
bond
make
octapeptid
avlqsgfr
distort
key
potenti
start
system
design
anti
sar
drug
spread
sever
acut
respiratori
syndrom
sar
asia
north
america
sever
countri
europ
prompt
unpreced
global
effort
fight
diseas
research
identifi
crucial
protein
sarscoronaviru
thousand
compound
screen
effort
find
new
drug
anand
et
al
base
experiment
pro
structur
human
coronaviru
hcov
porcin
transmiss
gastroenter
viru
tgev
complex
recent
crystal
structur
sar
cov
pro
differ
ph
valu
report
yang
et
al
xray
structur
reveal
differ
homolog
model
obtain
earlier
howev
experiment
structur
sar
cov
pro
fold
arrang
similar
hcov
tgev
pro
structur
homolog
model
experiment
structur
hisci
catalyt
dyad
domain
ii
structur
three
coronaviru
main
proteinas
reveal
remark
degre
conserv
substratebind
site
form
structur
basi
ration
drug
design
time
structurebas
drug
design
progress
base
molecular
structur
sarscov
pro
suggest
anand
et
al
could
well
serv
start
point
design
effici
inhibitor
sar
cov
pro
peptid
inhibitor
design
base
structur
hcov
pro
clinic
test
pfizer
treatment
human
common
cold
chou
et
al
found
defici
bind
sar
cov
pro
suggest
use
deriv
could
form
better
interact
activ
pocket
sar
cov
pro
chou
et
al
also
propos
octapeptid
inhibitor
nh
cooh
cleavag
site
indic
base
molecular
model
suggest
support
recent
work
yang
et
al
structur
determin
author
use
decad
peptid
nh
cooh
quit
similar
octapeptid
nh
cooh
accord
recent
report
gan
et
al
octapeptid
origin
propos
chou
et
al
synthes
test
activ
inhibit
replic
sar
coronaviru
compar
compound
report
moreov
found
octapeptid
toxic
vivo
physiolog
concentr
peptid
cleavabl
proteas
mean
good
bind
ligand
receptor
activ
region
proteas
peptid
scissil
bond
cleav
see
eg
comprehens
review
howev
one
need
make
chemic
modif
octapeptid
order
stabil
inhibit
power
sar
cov
pro
make
becom
effect
drug
may
realiz
base
distort
key
theori
reach
goal
detail
understand
cleavag
mechan
octapeptid
sar
cov
pro
well
structur
enzym
essenti
similar
strategi
use
investig
atp
complex
apoptosi
protein
betasecretas
zymogen
mani
use
insight
gain
studi
accordingli
expect
present
studi
may
also
provid
use
insight
develop
anti
sar
drug
proteasesuscept
site
given
protein
peptid
usual
extend
octapeptid
region
correspond
amino
acid
residu
sequenti
symbol
eight
subsit
r
r
r
r
r
r
r
r
eight
combin
posit
proteas
note
see
eg
well
fig
occasion
suscept
site
protein
may
contain
one
subsit
less
howev
eight
amino
acid
residu
common
case
although
protein
cleav
contain
much
eight
amino
acid
residu
usual
segment
octapeptid
fit
fig
schemat
draw
illustr
distort
key
theori
cleavag
locat
octapeptid
proteas
peptid
bond
r
r
b
chemic
modif
scissil
peptid
bond
chang
strong
hybrid
peptid
bond
cleavag
difficult
adapt
chou
permiss
activ
site
region
proteas
therefor
research
focu
cleavabl
octapeptid
shown
fig
combin
thin
line
dash
line
use
repres
conjug
properti
peptid
bond
fig
howev
scissil
peptid
bond
replac
strong
hybrid
peptid
bond
r
r
chemic
modif
enhanc
chemic
bond
becom
cleavabl
proteas
accord
distort
key
theori
cleavabl
octapeptid
liken
key
fit
well
bind
proteas
activ
region
lead
cleavag
scissil
bond
octapeptid
chemic
modif
still
bind
activ
region
peptid
bond
longer
cleav
proteas
thu
modifi
octapeptid
vividli
compar
distort
key
insert
lock
neither
open
easili
pull
lock
view
modifi
octapeptid
natur
becom
stabl
competit
inhibitor
potenti
candid
drug
octapetid
avlqsgfr
first
design
octapeptid
base
molecular
structur
sar
cov
pro
prove
cleavabl
experiment
studi
use
molecular
mechan
quantum
mechan
simul
investig
cleavag
mechan
properti
chemic
bond
concern
well
catalyt
interact
octapeptid
sar
cov
pro
studi
perform
follow
four
step
use
molecular
mechan
minim
energi
sar
cov
pro
complex
octapeptid
basi
deriv
dock
studi
comput
atom
charg
distribut
around
bind
pocket
sar
cov
pro
use
ab
initio
quantum
mechan
minim
conform
energi
comput
molecular
energi
chemic
bond
properti
atom
charg
octapeptid
background
charg
distribut
sar
cov
pro
use
ab
initio
quantum
mechan
back
ground
charg
distribut
comput
molecular
energi
chemic
bond
properti
atom
charg
modifi
octapeptid
dock
oper
octapeptid
avlqsgfr
sar
cov
pro
perform
base
homolog
structur
use
moe
molecular
oper
environ
program
packag
twentyf
dock
structur
obtain
one
optim
dock
score
use
energi
minim
fig
show
energyrefin
dock
structur
obtain
aforement
step
contrast
common
serin
proteas
serhisasp
catalyt
triad
sar
cov
pro
hisci
catalyt
dyad
similar
tgev
pro
hcov
pro
accord
chou
et
al
catalyt
activ
region
locat
within
pocket
domain
ii
sar
coronaviru
main
proteas
contain
follow
amino
acid
residu
fig
show
locat
catalyt
dyad
sar
cov
pro
activ
cleft
sar
cov
pro
well
accommod
octapeptid
ligand
bind
receptor
six
hydrogen
bond
fig
fulli
consist
result
report
chou
et
al
order
studi
influenc
sar
cov
pro
chemic
bond
octapeptid
consid
small
region
catalyt
cleft
surround
octapeptid
shown
fig
catalyt
dyad
front
peptid
bond
glnser
subsit
r
r
polar
hydrogen
h
n
midazol
group
point
peptid
bond
glnser
larg
influenc
activ
region
electrostat
interact
play
domin
role
ligandreceptor
combin
must
taken
consider
quantum
mechan
calcul
influenc
sar
cov
pro
chemic
bond
octapeptid
purpos
divid
amino
acid
residu
activ
cleft
domain
ii
sar
cov
pro
six
segment
comput
atom
charg
use
ab
initio
quantum
mechan
separ
fig
amino
acid
residu
six
segment
list
tabl
deduct
overlap
atom
total
atom
background
charg
includ
atom
catalyt
cleft
tabl
list
mulliken
atom
charg
q
mull
electrostat
potenti
equival
charg
q
esp
obtain
fit
atom
charg
electrostat
potenti
van
der
waal
surfac
atom
charg
semi
especi
q
esp
reason
q
esp
reproduc
quantum
mechan
electrostat
potenti
molecular
surfac
research
use
q
esp
calcul
illustr
point
seen
tabl
two
polar
hydrogen
atom
imidazol
group
larg
atom
charg
q
esp
atom
charg
polar
hydrogen
h
littl
smaller
atom
charg
proton
h
nitrogen
n
close
peptid
bond
glnser
subsit
r
r
polar
hydrogen
h
attract
electron
densiti
peptid
bond
glnser
weaken
chemic
bond
calcul
cleavag
reaction
energi
octapeptid
avlqsgfr
two
tetrapeptid
avlq
sgfr
use
ab
initio
gaseou
phase
molecular
energi
octapeptid
two
tetrapeptid
shown
tabl
hydrolyz
reaction
energi
kjmol
peptid
bond
consid
pseudo
bond
ie
partial
bond
consist
three
atom
four
electron
tabl
show
atom
coordin
six
atom
two
end
peptid
bond
gln
ser
xcoordin
six
atom
almost
carbonyl
group
co
glutamin
nitrogen
atom
n
nh
serin
form
bond
catalyt
dyad
activ
pocket
domain
ii
attract
electron
densiti
peptid
bond
glnser
caus
increas
posit
charg
c
co
glutamin
neg
charg
n
nh
serin
electrophil
proton
h
attack
n
nh
serin
neucleophil
oh
attack
c
co
glutamin
respect
catalyt
function
group
imidazol
ring
play
acidbas
catalyt
role
pk
valu
imidazol
group
histidin
concentr
h
water
henc
serv
good
proton
provid
life
condit
electron
densiti
counter
surround
atom
n
nh
c
co
form
two
triangl
like
sp
hybrid
orbit
therefor
x
orbit
three
atom
perpendicular
plane
form
bond
system
tabl
list
atom
charg
six
atom
side
peptid
bond
glnser
obtain
ab
inito
calcul
gaseou
phase
background
charg
sar
cov
pro
neg
charg
n
nh
serin
increas
sar
cov
pro
background
charg
gaseou
phase
posit
charg
carbonyl
carbon
c
co
glutamin
increas
background
charg
gaseou
phase
henc
favor
cleavag
reaction
fig
counter
map
electron
densiti
differ
peptid
bond
glnser
octapeptid
avlqsgfr
obtain
subtract
electron
densiti
gaseou
phase
electron
densiti
background
charg
sar
cov
pro
fig
grey
bold
line
line
mean
electron
densiti
gaseou
phase
proteas
background
charg
unchang
solid
thin
line
show
region
electron
densiti
greater
sar
cov
pro
background
charg
gaseou
phase
dash
thin
line
show
area
electron
densiti
smaller
proteas
background
charg
gaseou
phase
find
along
peptid
bond
gln
cn
ser
electron
densiti
increas
n
ser
side
decreas
gln
c
side
chang
favor
neucleophil
attack
anion
oh
gln
c
electrophil
attack
cation
h
n
ser
sar
cov
pro
high
select
polyprotein
cleavag
site
subsit
r
invari
occupi
gln
simpl
routin
way
make
octapeptid
avlqsgfr
effect
inhibitor
chang
cleavabl
scissil
peptid
bond
solid
singl
bond
chemic
modif
replac
carboxyl
group
co
glutamin
subsit
r
ch
cf
group
bond
system
broken
modifi
octapeptid
avlqsgfr
may
becom
compet
inhibitor
sar
cov
pro
effect
drug
candid
sar
show
possibl
chemic
modif
octapeptid
avlqsgfr
comput
model
tabl
list
atom
charg
six
atom
side
hybrid
peptid
bond
glnser
chang
carbonyl
group
co
gln
ch
group
compar
tabl
find
carbon
atom
ch
group
hybrid
peptid
bond
turn
neg
posit
charg
co
group
see
tabl
henc
neucleophil
attack
oh
imposs
hand
neg
charg
n
nh
ser
side
decreas
tabl
henc
electrophil
attack
h
difficult
third
row
tabl
atom
charg
background
charg
distribut
sar
cov
pro
atom
charg
c
ch
gln
side
henc
neucleophil
attack
oh
inde
difficult
octapeptid
nh
alavalleuglnserglyphearg
cooh
first
one
design
base
molecular
structur
sar
cov
pro
prove
cleavabl
octapeptid
experiment
last
eight
amino
acid
residu
decapeptid
use
yang
et
al
exactli
octapeptid
avlqsgfr
origin
investig
chou
et
al
cleavabl
octapeptid
could
chang
effect
inhibitor
sar
cov
pro
candid
anti
sar
drug
proper
chemic
modif
replac
scissil
peptid
bond
hybrid
peptid
bond
modifi
octapetid
lose
cleavabl
still
bind
activ
site
thu
becom
stabl
inhibitor
distort
key
number
possibl
octapeptid
huge
octapeptid
avlqsgfr
may
best
cleavabl
one
accordingli
search
potenti
inhibitor
matter
paramount
import
discern
kind
peptid
cleav
sar
cov
pro
kind
even
limit
rang
octapeptid
mean
easi
answer
question
would
exhaust
experiment
test
huge
number
possibl
octapeptid
good
cleavabl
octapeptid
could
found
use
exist
predict
algorithm
discrimin
function
algorithm
vector
sequencecoupl
algorithm
relev
algorithm
predict
method
success
appli
help
inhibitor
design
hiv
proteas
statist
predict
method
depend
train
set
known
sampl
predict
cleavabl
octapeptid
sar
cov
pro
need
two
type
set
one
posit
train
set
consist
cleavabl
octapeptid
neg
train
set
consist
uncleav
octapeptid
build
neg
train
set
easi
exampl
know
protein
consist
amino
acid
residu
cleavabl
sar
cov
pro
get
non
cleavabl
octapeptid
immedi
howev
build
posit
train
set
need
experi
comput
simul
molecular
model
good
way
acceler
procedur
method
conclus
research
help
purpos
